PLSE · Pulse Biosciences, Inc.
$34.56
-0.91 (-2.57%)
At close · Jul 29
Market Cap
$2.45B
Shares
69.21M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$35.47
Open$33.27
Day$32.86–36.29
52W$12.56–36.29
Avg vol 30d358K
Short int2.9M · 4.2% float · 11.6d
Short vol38%
Last earningsAug 6, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 14
Up next
Next earnings call
Aug 6, 2026
Scheduled
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+77%
above
Price vs 50-day avg
+32%
above
RSI (14)
72
overbought
MACD trend
Positive
52-week position
97%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+25%
trailing
6-month return
+159%
trailing
YTD return
+158%
this year
Relative strength
+151%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $27 › 200d $20 — 50d above 200d
Institutional flow
Accumulating
14 of 95 funds reported for Jun 30 · net +10.1K sh shares · +1 new
Insider flow
Accumulating
Net +$13.3M over 90 days · 0% sells
Short interest
Rising
4.18% of float · ▲ +1.2% MoM · 11.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
95 holders — near 3-yr high, broad support
Squeeze score
73
high risk · 0–100
Fundamentals
Free cash flow
$-54.4M
Balance sheet
$80.7M
net cash
Quant / Vol
risk profile
Volatility
87%
annualized · 1-yr
Max drawdown
−37%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+77%
Bullish
Price vs 50-day avg
+32%
Bullish
RSI (14)
72
Bearish
MACD trend
Positive
Bullish
52-week position
97%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $27 › 200d $20 — 50d above 200d
Institutional flow
Accumulating
14 of 95 funds reported for Jun 30 · net +10.1K sh shares · +1 new
Insider flow
Accumulating
Net +$13.3M over 90 days · 0% sells
Short interest
Rising
4.18% of float · ▲ +1.2% MoM · 11.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
95 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $13
Now $35 · 97%
52-wk high $36
vs 200-day avg +77%
vs 50-day avg +32%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cash used in operating activities | $14.6M | three months ended March 31, 2026 | — |
|
|
|||
| Non-GAAP costs and expenses non-GAAP | $55.4M | Full year 2025 | — |
| Non-GAAP net loss non-GAAP | $50.8M | Full year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PLSE
this stock
Pulse Biosciences, Inc.
|
$2.45B | +158.3% | — | — | 4.2% |
|
ISRG
Intuitive Surgical Inc
|
$127.82B | -36.1% | +20.5% | 41.5 | 1.9% |
|
MDLN
Medline Inc.
|
$53.22B | -3.5% | +11.5% | — | 2.2% |
|
BDX
Becton Dickinson & Co
|
$45.83B | +10.5% | +8.2% | 63.2 | 3.8% |
|
ALC
Alcon Inc
|
$33.70B | -12.3% | +10.5% | — | 2.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PLSE | +22.5% | +24.7% | +158.7% | +27.9% | +158.3% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | +23.5% | +24.7% | +151.3% | +28.7% | +149.7% |
Key facts
CIK
1625101
CUSIP
74587B101
13F (30d)
13 filings
13 filers
Visit website
Investor relations